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Abstract
Growth factors have been shown previously to participate in the process of axon target recognition. We showed that fibroblast growth
factor receptor (FGFR) signaling is required for Xenopus laevis retinal ganglion cell (RGC) axons to recognize their major midbrain target,
the optic tectum [neuron 17 (1996), 245]. Therefore, we have hypothesized that a change in expression of a fibroblast growth factor (FGF)
at the entrance of the optic tectum, the border between the diencephalon and mesencephalon, may serve as a signal to RGC axons that they
have reached their target. To determine whether RGC axons can sense changes in FGF levels, we asked whether they altered their behavior
upon encountering an ectopic source of FGF. We found that in vivo RGC growth cones avoided FGF-misexpressing cells along their path,
and that FGF-2 directly repelled RGC growth cones in an in vitro growth cone turning assay. These data support the idea that RGC axons
can sense changes in FGF levels, and as such provide a mechanism by which FGFR signaling is involved in RGC axon target recognition.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
The growth cone, a motile sensory apparatus at the tip of
a developing axon, interprets guidance cues in its environ-
ment. Such cues attract or repel growth cones, and act either
locally or at a distance from their site of production to direct
the growing axon through the brain to its target. In turn, the
effects of extrinsic cues on a growing axon are influenced
by the intrinsic state of the growth cone (Gomez and
Spitzer, 1999; McFarlane, 2000; Song et al., 1997, 1998).
Growth factors are one type of extrinsic cue that guide
axons. In vitro, the growth cones of Xenopus spinal cord
neurons are attracted by concentration gradients of several
growth factors, including brain-derived neurotrophic factor
(BDNF) and neurotrophin-3 (NT-3) (Song et al., 1997).
Moreover, several in vivo studies have illustrated a guid-
ance role for growth factors, particularly in target recogni-
tion (McFarlane and Holt, 1997). For instance, in BDNF
null mice, vestibular ganglion axons fail to innervate their
sensory epithelial target, a normal source of BDNF (Ernfors
et al., 1994). Further, target recognition by sympathetic
axons is dependent on nerve growth factor (NGF): Sympa-
thetic axons genetically engineered to misexpress NGF
grow out to, but fail to innervate their normal targets (Hoyle
et al., 1993). In addition, hepatocyte growth factor/scatter
factor (HGF/SF) in limb mesenchyme attracts incoming
chick motor axons (Ebens et al., 1996). Finally, we showed
previously that fibroblast growth factor receptor (FGFR)
signaling is required for Xenopus laevis retinal ganglion cell
(RGC) axons to recognize their major midbrain target, the
optic tectum (McFarlane et al., 1996). Inhibition of FGFR
signaling in RGC axons not only caused defects in their
ability to extend, but also led to target recognition errors
(McFarlane et al., 1996).
Several pieces of evidence have led us to hypothesize
that a change in fibroblast growth factor (FGF) levels at the
entrance to the optic tectum (i.e., the border between the
diencephalon and the mesencephalon) informs RGC axons
that they have arrived at their target. First, the expression
pattern of a number of FGFs changes at the entrance to the
optic tectum. For instance, we found that, in Xenopus,
FGF-2 protein is expressed at high levels along the optic
pathway, but at much lower levels in the optic tectum
(McFarlane et al., 1995). In contrast, Xenopus FGF-8
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mRNA is expressed at the anterior border of the optic
tectum (Christen and Slack, 1997). Additionally, FGF-15
mRNA is expressed in both the embryonic mouse dienceph-
alon and mesencephalon, but is absent from the border
between the two regions (Ford-Perriss et al., 2001; Mc-
Whirter et al., 1997). Second, we found that Xenopus RGC
axons fail to recognize their normal target when either
growth cone FGFRs are inhibited, or when the precise
spatial pattern of FGF expression is lost by broad applica-
tion of FGF-2 to the diencephalon as the axons approach the
optic tectum (McFarlane et al., 1995, 1996). Taken together,
these data suggest that a change in FGF levels at the en-
trance to the optic tectum acts as a target recognition cue for
RGC axons. Previous work has shown similarly that a
change in NGF levels is important for murine sympathetic
axons to recognize their target (Hoyle et al., 1993).
To determine whether RGC axons can sense changes in
FGF levels in vivo, we asked whether Xenopus RGC axons
alter their behavior when encountering an ectopic source of
FGF near or in the optic pathway. Guidance defects were
observed as RGC axons encountered brain neuroepithelial
cells that were made to misexpress FGFR ligands. Addi-
tional experiments showed that FGF-2 directly repelled
RGC growth cones in vitro. These data support our hypoth-
esis that RGC axons can sense changes in FGF levels, and
as such provide a mechanism by which FGFR signaling is
involved in RGC axon target recognition.
Materials and methods
Animals
Embryos were attained by fertilizing eggs obtained from
adult female X. laevis injected with human chorionic go-
nadotropin (Intervet). Embryos were kept in 0.1 Marc’s
Modified Ringer’s solution (MMR; 0.1 M NaCl, 2 mM KCl,
1 mM MgCl2, 5 mM Hepes, pH 7.5) with the temperature
varied between 14 and 27°C to control their speed of de-
velopment. Embryos were staged according to Nieuwkoop
and Faber (1994).
Constructs
The coding region of Xenopus embryonic fibroblast
growth factor (eFGF) (kindly provided by J. Slack; Isaacs et
al., 1992) was subcloned into the Stu/Xba sites of a modi-
fied CS2 cDNA expression vector (Turner and Weintraub,
1994) to generate CS2-eFGF. CS2 plasmids containing
either the coding regions of Xenopus fibroblast growth fac-
tor-2 (FGF-2; kindly provided by J. Slack) (Patel and Mc-
Farlane, 2000; Slack et al., 1987) or Xenopus FGFR li-
gand-2 (FRL-2; kindly provided by M. Kirschner)
(Kinoshita et al., 1995) were also used. A cDNA construct
encoding green fluorescent protein (GFP; CS2-GFP) was
used both as a reporter for transgene-expressing cells and as
a control.
DNA transfections and electroporation
Jelly coats of stage 24 embryos were removed by wash-
ing in 2% cysteine (pH 8.0), and embryos were then anes-
thetized in Modified Barth’s Saline [MBS; 8.8 mM NaCl,
0.1 mM KCl, 0.7 mM CaCl2, 0.1 mM MgSO4, 5 mM Hepes
(pH 7.8), 25 mM NaHCO3] supplemented with 0.4 mg/ml
tricaine (ethyl 3-aminobenzoic ethyl ester, methanesulfo-
nate salt; Sigma). The DNA transfection technique has been
described previously (Holt et al., 1990). In brief, DNA was
mixed with a synthetic cationic lipid (DOSPER or DOTAP;
Boehringer) at a 1:3 weight to volume ratio of DNA:trans-
fection reagent. A borosilicate glass needle, pulled on an
electrode puller (Sutter Instruments), was used with a Pico-
spritzer II (General Valve Company) to make multiple ex-
tracellular injections of the DNA mixture into stage 19 or 24
embryos, targeting the neuroepithelium that gives rise to the
diencephalon/midbrain. To obtain higher numbers of ex-
pressing cells, the embryo was electroporated (adapted from
Haas et al., 2001) following the last injection. Briefly, a total
of four to eight stimulations of 1 s each at the settings of 1
ms duration, 500 Hz and 150 V was applied to the brain by
using a S44 stimulator (Grass Instruments). Embryos were
allowed to develop at room temperature in 0.1MMR until
stages 33/34 or 40, and were then fixed overnight in 4%
paraformaldehyde in 1 phosphate-buffered saline (PBS,
pH 7.4) at 4°C.
Visualization of the optic projection
To visualize the optic projection, RGC axons were an-
terogradely labeled by using horseradish peroxidase (HRP,
type IV; Sigma) as described previously (Cornel and Holt,
1992). Briefly, the lens of the right eye was surgically
removed, and HRP, dissolved in 1% lysolecithin (Sigma),
was placed in the eye cavity. After allowing time for an-
terograde labeling of RGC axons (20 min), embryos were
fixed overnight at 4°C in 4% paraformaldehyde in 1 PBS
(pH 7.4). The brains were then dissected for whole-mount
immunocytochemistry.
BrdU labeling
Transfected embryos were injected in the gut with 5
mg/ml bromodeoxyuridine (BrdU; Sigma) diluted in MBS,
at stage 33/34. Two hours following injection, embryos
were fixed in 4% paraformaldehyde in 1 PBS overnight at
4°C. Twenty-micrometer transverse cryostat sections were
treated for 20 min with 2 M HCl at room temperature and
rinsed before being processed for immunocytochemistry
with an anti-BrdU antibody (Amersham Pharmacia Bio-
tech).
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Immunocytochemistry
Immunocytochemistry was performed either on whole-
mount brains or on 12- to 20-m cryostat transverse sec-
tions through the embryonic diencephalon and midbrain.
Embryos for cryostat sectioning were rinsed twice in 1
PBS (pH 7.4) and cryoprotected for 30 min in 30% sucrose.
Prior to sectioning, embryos were frozen in optimal cutting
Fig. 2. GFP-positive cells cotransfected with the FGF-2 cDNA plasmid reliably misexpress the FGF-2 transgene. (A–B) Lateral views of whole-mount stage
40 Xenopus brains transfected with GFP (A) or FGF-2 (B) plasmid at stage 24. HRP-labeled optic projections ignore GFP-misexpressing cells (arrowhead
in A), but avoid an FGF-2-misexpressing cell (arrowheads in B). (C–D) Transverse sections through the eyes and brain of a stage 33/34 embryo transfected
at stage 19 with GFP and FGF-2 cDNA plasmids. The majority of GFP-positive cells (C) are also immunolabeled with an antibody that recognizes Xenopus
FGF-2-misexpressing cells (D). Tec, tectum; ot, optic tract; Di, diencephalon; R, retina; D, dorsal; A, anterior; V, ventral. Scale bar in (A) is 50 m for (A–B).
Scale bar in (C) is 25 m for (C–D).
Fig. 1. RGC axons avoid FGF-misexpressing cells in vivo. Whole-mount stage 40 Xenopus embryo brains shown from a lateral view. Representative
examples of the behavior of HRP-labeled RGC axons (red) encountering either GFP (A–B), or GFP and eFGF (C–F) plasmid-expressing brain cells (green).
(B) and (D) are higher power views of boxed areas in (A) and (C), respectively. Brain cells transfected with both GFP and eFGF plasmids appear to have
differentiated and exhibit processes (arrows). Tec, tectum; ot, optic tract; Tel, telencephalon; Di, diencephalon; A, anterior; D, dorsal. Scale bar in (A) is 50
m for (A, C, and E). Scale bar in (B) is 25 m for (B, D, and F).
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Fig. 3. A non-FGF FGFR ligand also redirects RGC axons. (A–E) Lateral views of whole-mount Xenopus brains transfected with GFP (A), or GFP and FRL-2
(B–E) cDNA plasmids at stage 19. HRP-labeled RGC axons (red) ignored neuroepithelial cells misexpressing GFP (A, green), but avoided crossing over the
GFP and FRL-2-misexpressing cells (B and C, green). (C) shows the overlay of photomicrographs of the HRP-labeled optic tract (D) and the GFP/FRL2-
misexpressing cell (E). (F) Graph showing the percentage of optic projections that deviated around transfected cells misexpressing GFP alone (n  14), GFP
and eFGF (n  11), FGF-2 (n  10), and GFP and FRL-2 (n  8). Only cells misexpressing an FGFR ligand affected the RGC optic projection. D, dorsal;
A, anterior; ot, optic tract. Scale bar is 25 m for (A, C–E). Scale bar in (B) is 50 m.
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temperature (OCT) compound (Baxter), and quick-frozen at
20°C. Standard immunostaining procedures were used for
cryostat sections and whole-mount brains (Cornel and Holt,
1992; McFarlane et al., 1995). Samples were incubated
overnight at 4°C in primary antibody diluted in PBT [PBS,
0.1% bovine serum albumin (BSA) (Sigma), 0.5% Triton
(BDH)] with 5% goat serum (Invitrogen). Fluorescent sec-
ondary antibodies were applied for 1 h at room temperature.
After washing in PBT, samples were mounted in glycerol
with an anti-bleaching agent, p-phenylenediamine [1 mg/ml
in 9 parts glycerol, 1 part 1 M Tris–HCl (pH 8.5); Sigma].
Digital images of samples were obtained by using a Spot II
camera and Spot Advanced software (Diagnostics Instru-
ments), and processed for brightness and contrast by using
Adobe Photoshop (4.0) software. Primary antibodies used in
this study were as follows: mouse monoclonal anti-HRP
(Sigma) at a dilution of 1:2000 (0.22 mg/ml), mouse mono-
clonal anti-BrdU (Amersham Pharmacia Biotech) at a dilu-
tion of 1:4, and rabbit polyclonal FGF-2 antibody (R&D
Systems) at a dilution of 1:100 (10 g/ml). All antibodies
were visualized with the fluorescent mouse anti-Rhodamine
Red X (RRX) secondary antibody at a dilution of 1:500 (3
g/ml) (Jackson ImmunoResearch Laboratories, Inc.).
Retinal cultures
Eye primordia were dissected from stage 24 Xenopus
embryos and plated as explant tissue or dissociated cells on
poly-L-ornithine (Sigma) coverslips coated with 10 g/ml
laminin (Sigma) for neurite measurements (as per Harris et
al., 1985), or the cells were grown on 50 g/ml fibronectin
(Roche) for growth cone turning assays. For explant cul-
tures, culture media consisted of 60% L-15-glutamine (In-
vitrogen), 0.1% BSA, and 1% antibiotic–antimycotic (In-
vitrogen). For neurite outgrowth assays, dissociated retinal
cultures were grown either in the above solution (control) or
in control solution supplemented with either 20 or 250
ng/ml human recombinant FGF-2 (Invitrogen). After 24 h,
cultures were fixed for 45 min in 1% gluteraldehyde and
mounted in aquamount (Baxter). Analysis was performed
blind and involved measuring the longest uninterrupted neu-
rite of solitary RGCs using Spot II software (Diagnostic
Instruments). RGCs were easily identified on the basis of
morphology (Worley and Holt, 1996). Samples were statis-
tically analyzed by using an ANOVA test, followed by a
Student-Newmann-Keuls post-hoc test.
Growth cone turning assay
Stage 24 retinal explant cultures were used in the growth
cone turning assay 18–24 h after plating (as per de la Torre
et al., 1997). Growth cones that actively grew in a straight
line for 30 min before the beginning of the experiment were
chosen. The responses of these growth cones to an applied
concentration gradient were recorded for 45 min by using a
Cohu CCD video camera and Scion Image capture software
(shareware). Stable FGF-2 gradients were formed by pul-
satile ejection of 0.1 mg/ml recombinant human FGF-2
protein (Invitrogen) from a 0.5- to 1-m tip glass capillary
pipette placed at a 45° angle from the actively extending
growth cone (Lohof et al., 1992; Zheng et al., 1994). The
pressure was applied with an electrically gated pressure
application system (Picospritzer General Valve). A standard
pressure pulse of 3 p.s.i. in amplitude was applied for 20 ms
to the pipette at a frequency of 2 Hz using a pulse generator
(SD9, Grass Instruments). By this method, stable concen-
tration gradients can be established from the micropipette,
and, at a distance of 50–100 m away, the growth cone sees
a concentration approximately 1000-fold lower than in the
Fig. 4. FGF-misexpressing cells are postmitotic. Twenty micrometer trans-
verse sections through the eyes and midbrain of Xenopus embryos trans-
fected at stage 19 with GFP, or GFP and eFGF plasmids (green), and
injected with BrdU at stage 33/34. After 2 h, stage 35/36 embryos were
fixed, sectioned, and processed for BrdU immunocytochemistry (red). Few
neuroepithelial cells misexpressing GFP (A), or GFP and eFGF (B), were
BrdU-positive. Mb, midbrain; R, retina; D, dorsal; V, ventral; Ve, ventri-
cle. Scale bar is 50 m for (A–B).
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pipette (i.e., 100 ng/ml) (Lohof et al., 1992; Zheng et al.,
1994). Control solutions consisted of 1% BSA in 1 PBS.
Upon completion of the experiment, only actively extending
growth cones (5 m growth as per Zheng et al., 1994)
were analyzed. Experiments were performed blind so that
only after the analysis of the recorded video was the identity
of the pipette solution revealed to the experimenter. For
analysis, the trajectories of the growth cones were traced
onto a graph and the turning angles were measured.
Results
RGC axons avoid FGF-misexpressing cells in vivo
Based on our previous FGF signaling gain-and loss-of-
function data (McFarlane et al., 1995, 1996), we hypothe-
size that a change in FGF levels at the anterior border of the
midbrain acts as a target recognition signal for incoming
RGC axons. To determine whether RGC axons can sense
changes in FGF levels in vivo, ectopic sources of an FGF
were provided along the optic pathway. At stage 19 or 24,
we transfected brain neuroepithelial cells with a cDNA
plasmid encoding the secreted FGF protein Xenopus em-
bryonic-FGF (eFGF) (Isaacs et al., 1992). eFGF is not
expressed in the optic pathway, but given that FGFRs are
promiscuous with respect to ligand binding, ectopically
produced eFGF should activate axonal FGFRs (Greene et
al., 1998). While it is likely that other misexpressed growth
factors could affect the behavior of RGC axons, for example
BDNF (Cohen-Cory and Fraser, 1994), the purpose of our
experiments was to test whether this is the case for FGFs.
To visualize transgene-expressing cells, a reporter plasmid
encoding green fluorescent protein (GFP) was cotransfected
into the neuroepithelial cells. Transfection of the GFP plas-
mid alone served as the control. At stage 40, when normally
the optic tract has innervated the target, RGC axons were
anterogradely labeled with HRP, and whole-mount brains
were processed with an antibody that recognizes HRP.
In controls, RGC axons that encountered GFP-positive
cells in the optic pathway ignored the cells and grew along
their normal path toward the optic tectum (Figs. 1A and B,
2A, and 3A; n  14 embryos). In contrast, RGC axons
consistently turned to avoid eFGF-misexpressing cells (Fig.
1C–F; n  11 embryos). It was clear in some cases that the
axons turned at a distance of at least one cell diameter from
the eFGF-expressing cell (Fig. 1D and E). Axons were
misdirected whether they encountered single (Fig. 1C–E) or
multiple (Fig. 1F) eFGF-misexpressing cells, and whether
the cells were in the optic tract (Fig. 1C and D) or optic
tectum (Fig. 1E and F). These data indicate that an ectopic
FGF source affects RGC growth cone behavior at a dis-
tance.
To confirm that the GFP-positive cells also misexpressed
FGF protein, we performed identical experiments with a
construct encoding Xenopus FGF-2 (Kimelman and Kirsch-
ner, 1987; Slack et al., 1987), as an antibody that recognizes
this protein is commercially available (Patel and McFarlane,
2000). FGF-2-overexpressing cells caused defects in the
trajectories of RGC axons similar to those observed with
eFGF misexpression; however, the axons came into closer
proximity to the FGF-2-expressing cells before they altered
their trajectory (Fig. 2B; n  10 embryos). Immunocyto-
chemistry revealed that 93% of GFP-positive cells coex-
pressed the FGF-2 protein (n  200 cells; Fig. 2C and D).
Given this high coexpression rate, and the similar avoidance
phenotype observed with all the eFGF and FGF-2 but none
of the GFP-transfected embryos, it is likely that a compa-
rable coexpression rate is obtained with eFGF and GFP
coinjections.
Misexpression of a non-FGF ligand that interacts with
FGFR also redirects RGC axons
Several proteins that are not members of the FGF family
can also bind to and activate FGFRs. One of these is the
FGFR ligand-2 (FRL-2) (Kinoshita et al., 1995). To deter-
mine whether ectopic expression of FRL-2 could also mis-
direct RGC axons, we cotransfected FRL-2 and GFP cDNA
plasmids into the developing Xenopus neuroepithelium at
stages 19 or 24 and assayed the behavior of HRP-labeled
axons at stage 40. The cells misexpressing the reporter
protein GFP did not affect RGC axon trajectories (Fig. 3A;
n 14). In contrast, in all cases of RGC axons encountering
ectopic FRL-2-expressing cells, the axons preferred to grow
on adjacent cellular substrate (Fig. 3B–E; n  8 embryos).
While we were unable to confirm that the cells were ex-
pressing FRL-2, we feel confident that this was the case,
since avoidance was observed whenever axons encountered
Fig. 5. Low and high FGF-2 concentrations stimulate RGC neurite exten-
sion in vitro. Stage 24 eyebuds were dissociated and cultured for 24 h in
60% L-15-glutamine with 0.1% BSA, or in this media supplemented with
20 or 250 ng/ml human recombinant FGF-2. RGCs were easily identified
as having a large, phase bright cell body with one to three long processes
(as per Worley and Holt, 1996). The length of their longest uninterrupted
neurite was measured. Lengths averaged for five to six independent exper-
iments are shown. Both low and high concentrations of FGF-2 significantly
stimulated neurite extension over and above that observed in control (*, P
 0.05, ANOVA, Student-Newmann-Keuls post-hoc test).
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Fig. 6. FGFs directly repel RGC growth cones in vitro. RGC growth cones extending from a 24-h, stage 24 explant culture. A pipette with a 0.5- to 2.0-m
opening (black star) was used to eject in a pulsatile fashion either control media (A–B), or an FGF-2-containing media (C–D), onto an extending RGC growth
cone. (A, C) Growth cones prior to applying the pipette solution. (B, D) Growth cones 45 min after continuous exposure to the applied pipette solution. The
growth cone does not respond to the control solution (A–B), but is redirected away from the pipette ejecting FGF-2 (C–D). (E–F) Superimposed neurite
trajectories of growth cones exposed to control (E) and FGF-2 (F)-containing pipettes. Scale bar in (A) is 25 m.
FRL-2-expressing cells but never when encountering GFP-
expressing cells, and the FGF-2 construct showed high
coexpression rates with GFP (Fig. 2C and D). These data
indicate that different FGFR ligand families can redirect
RGC axons in vivo (Fig. 3F).
The FGF-misexpressing neuroepithelial cells are
postmitotic
There are several explanations for the misdirection of
RGC axons caused by FGF-misexpressing cells. First, FGFs
are known to act as strong mitogens in the developing
nervous system (Gospodarowicz and Bialeki, 1979;
Michler-Stuke and Bottenstein, 1982). It is possible that
FGF-misexpressing cells and their neighbors remain mitot-
ically active, so that the diencephalic environment would be
unlike that of the stage 33/34 brain through which the RGC
axons normally extend. To test this possibility, at stage
33/34, we injected eFGF and/or GFP-transfected embryos
with bromodeoxyuridine (BrdU), which labels proliferative
cells. The GFP-expressing cells (Fig. 4A) and the GFP/
eFGF coexpressing cells (Fig. 4B) showed little colabeling
with BrdU (12%, n  128; 7%, n  135, respectively),
indicating that in both cases the vast majority of transfected
cells were postmitotic. Indeed, many of the GFP/eFGF
coexpressing cells had a differentiated morphology, with
long processes (Fig. 1D and F, arrows). These data argue
against the possibility that the FGF-misexpressing cells re-
mained undifferentiated and thus failed to provide the ap-
propriate cues for RGC axon pathfinding.
High and low FGF concentrations stimulate RGC axon
extension in vitro
FGF-2 is known to stimulate neurite extension of cul-
tured Xenopus RGCs and rat cerebellar neurons (McFarlane
et al., 1995; Williams et al., 1994); however, at high doses,
FGF-2 fails to promote extension in rat cerebellar neuron
cultures (Williams et al., 1994). In our in vivo experiments,
FGFs were misexpressed at high levels. As such, it is
possible that the ectopic FGF could be inhibitory to RGC
axon extension and thus cause defects in the development of
the optic tract. To determine whether high concentrations of
FGFs adversely affect RGC axon extension, we cultured
dissociated stage 24 retinal cultures in the presence of low
(20 ng/ml; n  6 independent cultures) or high (250 ng/ml;
n  5 independent cultures) levels of human recombinant
FGF-2 protein. We showed previously that the former con-
centration promotes RGC neurite outgrowth (McFarlane et
al., 1995). RGCs are easily identifiable in the dissociated
cultures (Worley and Holt, 1996), and the length of their
longest neurite was measured. There was no obvious dif-
ference in neurite length when the cultures were exposed to
high or low concentrations of FGF-2 (Fig. 5; *, P  0.05,
ANOVA, Student-Newmann-Keuls post-hoc test). Thus, an
FGF-2 concentration that failed to promote rat cerebellar
neurite outgrowth was still stimulatory to RGC axon exten-
sion (Williams et al., 1994). Therefore, it is unlikely that the
FGF-misexpressing cells affected the development of the
optic tract by inhibiting axon extension.
FGFs directly alter RGC growth cone trajectories in vitro
To determine whether FGFs act as a chemotropic mole-
cule for RGC axons, we used an in vitro growth cone
turning assay (Lohof et al., 1992; Zheng et al., 1994).
Eyebuds were explanted at stage 24 and cultured for 18–24
h before performing the turning assay on RGC growth cones
that had extended from the explant (de la Torre et al., 1997).
Sister embryos allowed to develop for the same time period
would be at stage 33/34, and their RGC axons would be
extending through the diencephalon (Holt, 1989). Previ-
ously, we showed that cultured RGC growth cones express
FGFRs (McFarlane et al., 1996). RGC growth cones were
first recorded for 30 min by using time-lapse videomicros-
copy. Subsequently, either control media (0.1% BSA in
PBS) or control media supplemented with 0.1 mg/ml FGF-2
was applied to one side of the growth cone by pulsatile
ejection, and growth cones were recorded for an additional
45 min. In the majority of cases (87.5%, n  8), control
media did not affect the growth cone trajectory (Fig. 6A, B,
and E). In contrast, several RGC growth cones (50%, n 8)
turned away from the FGF-2-containing pipette (Fig. 6C, D,
and F). A trace of the paths taken by all growth cones in
response to a control or an FGF-2 source is represented in
Fig. 6E and F. The mean turning angle of RGC growth
cones when presented with an FGF-2 source (17.9° 
8.1° s.e.m, n  8) was significantly different from that of
control axons (1.0° 1.7° s.e.m, n 8; P 0.05, unpaired,
two-tailed Student’s t test). These data indicate that FGFs
directly repel RGC axons in vitro, and suggest that FGF-
dependent chemorepulsion is the explanation for why RGC
axons avoid FGF-misexpressing cells in vivo.
Discussion
In this study, we demonstrated that developing RGC
axons sense changes in FGF levels in vivo and in vitro. We
showed that in vivo, FGF-misexpressing cells along the
optic tract or within the optic tectum caused RGC axon
pathfinding errors, presumably in an FGFR-dependent man-
ner. In vitro, we illustrated that FGFs directly repel RGC
growth cones in a growth cone turning assay. These data
indicate that RGC axons are sensitive to FGF levels both in
vivo and in vitro and that FGFs can act as chemorepellents.
In vivo, the ectopic FGF could influence RGC axons
directly or indirectly through a signal produced by the
transgene-expressing cell or its neighbors. For the following
reasons, we favor the former explanation. First, we found
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that RGC growth cones turned away from an FGF-2 source
in vitro. Importantly, previous work has shown that, under
similar experimental conditions, RGCs cultured on fi-
bronectin grew toward, not away from, a source of the
growth factor netrin (Hopker et al., 1999), arguing for the
specificity of the FGF-2 effect. This is the first demonstra-
tion that FGFs are chemotropic for developing axons,
though FGF-10 has been shown to act as a chemoattractant
for distal epithelial buds during lung development (Park et
al., 1998). Second, the BrdU labeling experiments suggest
that the differentiation of FGF-misexpressing cells and their
neighbors was unaffected, despite the known mitogenic
activity of FGFs (Gospodarowicz and Bialeki, 1979;
Michler-Stuke and Bottenstein, 1982). As such, it seems
likely that the avoidance of FGF-misexpressing cells by
RGC axons in vivo is also explained by a direct chemore-
pulsive action of FGF on RGC axons. The fact that the RGC
axons often appeared to change their direction at a distance
from eFGF-expressing cells supports this idea. However,
the FGF-2- and FRL-2-misexpressing cells did not affect
axon behavior at a distance, leaving the possibility that in
vivo, a different mechanism, such as contact-mediated re-
pulsion, is occurring. The fact that members of two different
molecular families, FGFs and FRL-2, produced the same
repulsion of RGC axons implicates a signal transduction
cascade initiated through FGFR–ligand interaction.
The demonstration that RGC growth cones extending in
vitro, and presumably in vivo, can sense changes in local
FGF concentration lends further support to our model that it
is a change in FGF levels at the border to the optic tectum
that serves as a target recognition cue for RGC axons.
Indeed, there is a change in the expression of several FGFs,
including FGF-2, FGF-8, and FGF-15, at the border be-
tween the diencephalon and mesencephalon (Christen and
Slack, 1997; McFarlane et al., 1995; McWhirter et al.,
1997). Given that target recognition defects are observed
when the pattern of FGF expression is disrupted (McFarlane
et al., 1995), this ability to sense a change in FGF concen-
tration may be critical for normal RGC axon target recog-
nition.
How might FGF chemotropism be involved in RGC
axon target recognition? While we found that exogenous
FGFs were chemorepulsive in vivo and in vitro, it does not
necessarily mean that the endogenous FGFs at the border to
the optic tectum similarly act as chemorepellents. Growth
cone behavior in response to specific cues appears to be
context-dependent. For instance, altering intracellular
growth cone cyclic nucleotide levels dramatically affected
how cultured Xenopus growth cones responded to gradients
of netrin and BDNF (de la Torre et al., 1997; Song et al.,
1997). In both cases, lowering cyclic adenosine monophos-
phate (cAMP) converted an attractive turning response to
one of repulsion. In addition, the response of cultured RGC
growth cones to netrin depended on the levels of the extra-
cellular matrix molecule laminin (Hopker et al., 1999).
Thus, FGFs could act as either an attractant or a repellent for
RGC axons reaching the anterior border of the optic tectum.
Previous studies suggest explanations for why we found
in vitro that FGFs applied locally in a concentration gradient
were repulsive to RGC axons and yet FGF-2 induced RGC
neurite outgrowth when bath applied at a uniform concen-
tration. First, the internal state of the growth cone could
affect one process but not the other. For instance, lowering
cAMP activity changed netrin from an attractive to a repul-
sive influence on Xenopus spinal cord neuron growth cones,
but did not affect the rate of growth cone extension (Ming
et al., 1997). Second, different FGFR intracellular signaling
cascades may participate in RGC axon extension and turn-
ing. Indeed, the phosophinositol-3-kinase (PI3K) pathway is
important for FGF-dependent Xenopus RGC axon extension
but not for RGC target recognition (Lom et al., 1998). In
addition, glial cell line-derived neurotrophic factor pro-
motes survival and differentiation of pheochromocytoma
cells through the mitogen-associated protein kinase pathway
and the PI3K pathway, respectively (Chen et al., 2001).
Finally, it is possible that an axon’s response to a cue
depends on how that cue is presented to the cell or growth
cone. For instance, FGF-2 was chronically bath applied to
the entire cell in the extension assay, but was applied tran-
siently to one side of the growth cone in the turning assay.
In summary, this study is the first to show that FGFs
affect the trajectories of axons extending both in vitro and in
vivo, and that FGF can act as a chemorepellent. Classically,
in the absence of cyclic nucleotide manipulation, growth
factors such as BDNF and NT-3 are considered chemoat-
tractant molecules (Song et al., 1997). In the future, it will
be important to determine whether FGFs act chemotropi-
cally to influence the target recognition of RGC axons.
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